HEALTHSTORY 526· JULY 4, 2026

Roche Drug Sets New Standard for KRAS-Driven Lung Cancer

A Roche drug has established a new treatment standard for KRAS-driven lung cancer, STAT+ reported, marking a significant moment in an oncology target that has long resisted effective therapy. The news lands as the broader biotech sector's…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 525FBI Director Kash Patel Filed Late Disclosure on Strategy Stock, Reports Say NEXT STORY 527 →North Island Credit Union Collects School Backpacks for San Diego Youth Through Boys & Girls Clubs Partnership

Keep reading

More from the desk.

20HEALTH

Autoimmune research pioneer Georg Schett co-founds his first biotech, choosing antibody therapies over CAR-T

Georg Schett, the German scientist who spent five years demonstrating that CAR-T therapy, a treatment that engineers a patient's own immune cells to target and eliminate the source of disease, can reset the immune system in autoimmune…

health2 MIN

36HEALTH

Splitting the MMR vaccine risks more missed doses and more sick children, history suggests

Separating the MMR vaccine into individual shots is likely to produce more missed doses and more sick kids. The MMR is a single injection covering measles, mumps, and rubella. It is now the target of a White House executive order

health2 MIN

38HEALTH

FDA Rejects ITM's Cancer Drug on Manufacturing Grounds, Blocking Novartis Rival

A manufacturing problem flagged by U.S. regulators has halted a radiopharmaceutical, a cancer therapy that works by delivering radioactive isotopes directly to tumor cells. The drug's maker, ITM Isotope Technologies Munich SE, had already…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk